1. Denmark Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Demant A/S

Demant A/S

WILLF
Demant A/SUS flagOther OTC
41.51
USD
- -
- -
8.75BMarket Cap
Demant A/S
WILLF
(Other OTC)

Recent

price

41.51

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
23.6
27.63
30.02
31.65
33.6
39.48
45.51
51.41
55.94
61.37
60.34
76.25
87.19
96.81
103.21
- -
Revenue per Share
3.38
4.12
4.05
4.54
4.77
5.32
5.53
6.84
7.32
6
4.68
10.7
9.21
8.04
10.99
- -
Basic EPS, GAAP
1.89
3.34
3.31
3.1
4
4.44
5.16
6.08
5.03
6.48
8.82
12.21
7.51
16.24
15.2
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
35.9
34.17
37.24
41.85
43.52
- -
Book Value per Share
2.36
4.29
4.95
5.09
5.68
1.94
0.75
2.11
-3.24
-3.82
-3.44
-9.95
-17.79
-18.83
-24.96
- -
Tangible Book Value per Share
292
291
285
283
278
270
264
257
249
244
240
235
226
223
217
- -
Basic Weighted Avg Shares
6,892
8,041
8,555
8,959
9,346
10,665
12,002
13,189
13,937
14,946
14,469
17,905
19,705
21,601
22,419
22,971
Sales/Revenue/Turnover
20.75
21.18
19.18
18.83
18.15
17.16
15.51
17.33
17.21
13.6
7.08
19.79
15.66
20.55
19.2
17.08
Operating Margin (%)
- -
233
267
292
294
325
404
404
446
959
1,048
1,065
1,176
1,293
1,435
1,519
Depreciation Expense
988
1,198
1,153
1,285
1,326
1,436
1,459
1,754
1,823
1,462
1,121
2,513
2,082
1,795
2,387
1,545
Net Income, GAAP
24.81
25.34
24.33
22.72
21.53
20.45
20.48
21.01
22.72
23.23
15.12
21.67
22.24
24.62
22.17
23.67
Effective Tax Rate (%)
14.34
14.9
13.48
14.34
14.19
13.46
12.16
13.3
13.08
9.78
7.75
14.04
10.57
8.31
10.65
6.73
Profit Margin (%)
193
529
-784
-887
-1,133
-321
-705
-363
-1,481
-1,930
-687
-3,087
-1,547
2,522
3,826
2,652
Working Capital
1,045
1,011
76
81
9
2,080
1,960
2,339
2,164
4,058
4,936
4,405
7,864
12,216
14,591
18,982
LT Debt
2,443
3,304
4,059
5,056
5,584
6,500
6,966
7,433
7,059
7,645
8,279
7,981
8,562
9,338
9,644
9,919
Total Equity
25.73
23.81
19.89
17.22
15.23
13.9
12.13
14.02
13.54
9.77
4.96
15.14
11.19
14.05
13.52
10.58
Return on Invested Capital (%)
47.61
50.46
47.77
43.88
39.8
33.47
27.92
32.07
29.4
18.36
8.72
13.96
10.4
9.26
11.79
8.5
Return on Capital (%)
1,688.89
2,065.52
1,987.93
2,234.78
2,326.32
2,587.39
2,727.1
3,340.95
3,574.51
2,953.54
25.9
30.22
25.33
20.22
25.41
32.54
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.43%
3.77%
2.85%
Free Cash Flow
15.84%
18.01%
-9.27%
Net Income, GAAP
7.36%
18.19%
-35.27%
Sales/Revenue/Turnover
8.18%
9.93%
2.46%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
21,601
2024
- -
- -
- -
- -
22,419
2025
- -
- -
- -
- -
22,971

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
8.04
2024
- -
- -
- -
- -
10.99
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
HeartSciences Inc. (HSCS)
Oventus Medical Limited (OVN.AX)
Photoelectron Corp. (PECN)
UFP Technologies, Inc. (UFPT)
Circassia Group Plc (CIR.L)
Cytek Biosciences, Inc. (CTKB)
Business
Demant A/S (Ticker: WILLF) is a global hearing healthcare and audio technology company that develops, manufactures, sells and distributes hearing aids, diagnostic equipment, hearing care services and related solutions to help people with hearing loss connect and communicate. The company operates through three primary business areas: Hearing Aids, including premium brands such as Oticon, Bernafon, Sonic and Philips Hearing Solutions; Hearing Care, comprising a retail network of approximately 3,500 clinics worldwide under brands like Audika, HearingLife, Hidden Hearing and others, providing personalized hearing care services; and Diagnostics, offering audiometric and balance assessment equipment through brands including Interacoustics, Maico Diagnostics, Grason-Stadler, Amplivox, MedRx and AudioScan. Demant conducts operations in more than 30 countries across Europe, North America, Asia-Pacific and other regions, serving customers in over 130 countries with more than 22,000 employees and annual revenue exceeding DKK 22 billion. Founded in 1904 and headquartered in Smørum, Denmark, the company was rebranded from William Demant Holding A/S to Demant A/S in 2019. Recent strategic developments include the completion of the acquisition of Germany's KIND Group in December 2025 for approximately EUR 700 million, adding around 650 hearing care clinics and strengthening Demant's position in the key German market; the divestiture of Oticon Medical's hearing implants business to Impilo for up to DKK 600 million, announced in late 2025, concluding its exit from that segment; and a EUR 100 million loan from the Nordic Investment Bank in December 2024 to fund R&D investments in hearing healthcare products and technologies through 2025. Earlier expansions encompassed the 2022 acquisition of Chinese retailer ShengWang with 500 clinics and the 2024 announcement to explore a sale of its EPOS communications division focused on premium audio headsets for enterprise and gaming. These moves align with Demant's focus on scaling its core hearing care and aids businesses amid demographic-driven market growth.

Company News

APIChatGPT

  • defenseworld.net

    Demant A/S (OTCMKTS:WILLF) Short Interest Up 20.6% in March

  • defenseworld.net

    Demant A/S (OTCMKTS:WILLF) Sees Significant Increase in Short Interest

  • defenseworld.net

    Demant A/S (OTCMKTS:WILLF) Shares Up 2.1% – Still a Buy?

  • defenseworld.net

    Demant A/S (OTCMKTS:WILLF) Stock Price Up 0.2% – Time to Buy?